This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elsevier And The Dutch Fulbright Center Start Collaboration To Support Early Career Researchers In The Netherlands

AMSTERDAM, November 27, 2012 /PRNewswire/ --

Elsevier , a world-leading provider of scientific, technical and medical information products and services, today announces its collaboration with the Dutch division of the Fulbright Center, a bi-national non-profit organization focused on enhancing the collaboration between the United States and the Netherlands in science.

The collaboration between Elsevier and the Dutch Fulbright Center aims to provide support and guidance to young researchers in the Netherlands in the broadest sense. Activities will range from providing advice in relation to writing and publishing research papers, networking, funding and career planning. Planned Elsevier- Fulbright activities are:
  • Participation in Elsevier's Early Career Researcher Program; workshops in which young researchers are advised on how they can successfully write and publish their research papers and on how to get funding for conducting research abroad through a Fulbright scholarship.
  • Sponsoring of two Elsevier / Fulbright PhD scholarships in 2013 (more information available at
  • Providing free access to ScienceDirect and Scopus from 2013 onwards for Dutch Fulbright Scholars.

"A Fulbright scholarship stands for more than financial support alone. It provides guidance, opens doors to social events and other career-building activities," said Marcel Oomen, Director of the Dutch Fulbright Center. "Our participation in Elsevier's Early Career Researcher Program is a new part of our own program, as is the service that our grantees now have free access to ScienceDirect and Scopus. We are very happy to be working with Elsevier and hope it will enrich the experience of our grantees."

Martin Tanke, Managing Director Journals at Elsevier, added, "In today's competitive academic world it is a challenge for young researchers to build a successful research career. At Elsevier we aim to provide optimal career guidance and support to researchers who want to build their careers more effectively."

# # #

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,777.06 +304.69 1.85%
S&P 500 1,985.89 +34.53 1.77%
NASDAQ 4,777.6030 +69.8280 1.48%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs